792970-21-9

Usage

Uses

Used in Pharmaceutical Industry:
(3R)-N,1-dimethylpyrrolidin-3-amine is utilized as a chiral building block for the synthesis of various drugs and biologically active compounds, leveraging its unique stereochemistry to influence the properties and efficacy of the resulting pharmaceuticals.
Used in Chemical Research and Synthesis:
As a reagent, (3R)-N,1-dimethylpyrrolidin-3-amine is employed in chemical research and synthesis processes, where its specific structural features can be harnessed to achieve desired outcomes in chemical reactions.
Used in Organic Electronics and Materials Science:
(3R)-N,1-dimethylpyrrolidin-3-amine may be used as a component in the development of organic electronic devices and materials, capitalizing on its molecular structure and properties to contribute to advancements in these fields.

Upstream product

• 64021-81-4 benzyl-methyl-(1-methyl-pyrrolidin-3-yl)-amine 
• 346691-01-8 3-N-tert-butoxycarbonyl-3-(R)-amino-1-methylpyrrolidine 
• 122536-77-0 3-N-tert-butoxycarbonyl-3-(R)-aminopyrrolidine 

Relevant academic research and scientific papers

FUSED RING COMPOUND FOR USE AS MINERALOCORTICOID RECEPTOR ANTAGONIST

The present invention belongs to the technical field of medicine, relating in particular to: a fused ring compound as represented by Formula (I) for use as a mineralocorticoid receptor antagonist, a pharmaceutically acceptable salt thereof, and an isomer thereof; a preparation method for these compounds; a pharmaceutical preparation containing these compounds; and an application of these compounds, the pharmaceutically acceptable salt thereof, or the isomers thereof in the preparation of medicants for the treatment and/or prevention of kidney injury, cardiovascular diseases such as hypertension, and/or endocrine disease. The definitions of X, Y1, Y2, Y3, R1, R2a,R2b , R3a , R3b, R4, Cy and n are as presented in the description.

Fused Ring Compound For Use As Mineralocorticoid Receptor Antagonist

The present invention belongs to the technical field of medicine, relating in particular to: a fused ring compound as represented by Formula (I) for use as a mineralocorticoid receptor antagonist, a pharmaceutically acceptable salt thereof, and an isomer thereof; a preparation method for these compounds; a pharmaceutical preparation containing these compounds; and an application of these compounds, the pharmaceutically acceptable salt thereof, or the isomers thereof in the preparation of medicants for the treatment and/or prevention of kidney injury, cardiovascular diseases such as hypertension, and/or endocrine disease. The definitions of X, Y1, Y2, Y3, R1, R2a, R2b, R3a, R3b, R4, Cy and n are as presented in the description.

PYRAZOLOPYRIMIDINES

This invention relates to compounds of formula (I).

5,7-DIAMINOPYRAZOLO`4,3-D!PYRIMIDINES USEFUL IN THE TREATMENT OF HYPERTENSION

This invention relates to compounds of formula (I).

3-aminopyrrolidine compound and process for preparation thereof

Disclosed is a novel compound of 3-aminopyrrolidine having the formula (I): STR1 in which R1 is hydrogen, an alkyl, an aralkyl or an aryl.

N-substituted 3-aminopyrrolidines

The compounds 3-(N-diethylcarbamyl)amino-1-methyl pyrrolidine, 3-(N-carbethoxy-N-methyl)amino-1-methyl pyrrolidine, 1-diethylcarbamyl-3-(N-methyl)amino pyrrolidine and 1-diethylcarbamyl-3-dimethylamino pyrrolidine, said compounds having utility as antifilarial agents.